The Dendritic Cell Receptor DC-SIGN Discriminates among Species and Life Cycle Forms of Leishmania

Journal of Immunology

Volumn 172, Issue 2, 2004, Pages 1186-1190

  Colmenares, María ^a   Corbí, Angel L ^a   Turco, Salvatore J ^b   Rivas, Luis ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; CELL RECEPTOR; GLYCOCONJUGATE; LECTIN; LIPOPHOSPHOGLYCAN;

AMASTIGOTE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DENDRITIC CELL; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEISHMANIA; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA PIFANOI; LIFE CYCLE; MOLECULAR RECOGNITION; NONHUMAN; PARASITE SURVIVAL; PRIORITY JOURNAL; PROMASTIGOTE; SKIN LEISHMANIASIS; SPECIES; VISCERAL LEISHMANIASIS;

EID: 1642495738     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.2.1186     Document Type: Article

References (39)

1. Colmenares, M., S. Kar, K. Goldsmith-Pestana, and D. McMahon-Pratt. 2002. Mechanisms of pathogenesis: differences amongst Leishmania species. Trans. R. Soc. Trop. Med. Hyg. 96(Suppl. 1):S3.
2. McDowell, M. A., M. Marovich, R. Lira, M. Braun, and D. Sacks. 2002. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect. Immun. 70:3994.
3. Chaussabel, D., R. Tolouei Semnani, M. A. McDowell, D. Sacks, A. Sher, and T. B. Nutman. 2003. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 27:27.
4. Marovich, M. A., M. A. McDowell, E. K. Thomas, and T. B. Nutman. 2000. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J. Immunol. 164:5858.
5. von Stebut, E., Y. Belkaid, T. Jakob, D. L. Sacks, and M. C. Udey. 1998. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188:1547.
6. Konecny, P., A. J. Stagg, H. Jebbari, N. English, R. N. Davidson, and S. C. Knight. 1999. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. Eur. J. Immunol. 29:1803.
7. Ponte-Sucre, A., D. Heise, and H. Moll. 2001. Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells. Immunology 104:462.
8. Jebbari, H., A. J. Stagg, R. N. Davidson, and S. C. Knight. 2002. Leishmania major promastigotes inhibit dendritic cell motility in vitro. Infect. Immun. 70:1023.
9. Mosser, D. M. 1994. Receptors on phagocytic cells involved in microbial recognition. Immunol. Ser. 60:99.
10. Colmenares, M., A. Puig-Kroger, O. M. Pello, A. L. Corbi, and L. Rivas. 2002. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J. Biol. Chem. 277:36766.
11. Appelmelk, B. J., I. Van Die, S. J. Van Vliet, C. M. Vandenbroucke-Grauls, T. B. Geijtenbeek, and Y. Van Kooyk. 2003. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170:1635.
12. Relloso, M., A. Puig-Kroger, O. M. Pello, J. L. Rodriguez-Fernandez, G. de la Rosa, N. Longo, J. Navarro, M. A. Munoz-Fernandez, P. Sanchez-Mateos, and A. L. Corbi. 2002. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-P, and anti-inflammatory agents. J. Immunol. 168:2634.
13. Orlandi, P. A., Jr., and S. J. Turco. 1987. Structure of the lipid moiety of the Leishmania danovani lipophosphoglycan. J. Biol. Chem. 262:10384.
14. Thomas, J. R., M. J. McConville, J. E. Thomas-Oates, S. W. Homans, M. A. Ferguson, P. A. Gorin, K. D. Greis, and S. J. Turco. 1992. Refined structure of the lipophosphoglycan of Leishmania donovani. J. Biol. Chem. 267:6829.
15. Descoteaux, A., and S. J. Turco. 2002. Functional aspects of the Leishmania donovani lipophosphoglycan during macrophage infection. Microbes Infect. 4:975.
16. Pan, A. A. 1984. Leishmania mexicana: serial cultivation of intracellular stages in a cell-free medium. Exp. Parasitol. 58:72.
17. Armson, A., S. W. Kamau, F. Grimm, J. A. Reynoldson, W. M. Best, L. M. MacDonald, and R. C. Thompson. 1999. A comparison of the effects of a benzimidazole and the dinitroanilines against Leishmania infantum. Acta Trop. 73:303.
18. Lawrie, J. M., P. R. Jackson, J. M. Stiteler, and W. T. Hockmeyer. 1985. Identification of pathogenic Leishmania promastigotes by DNA: DNA hybridization with kinetoplast DNA cloned into E. coli plasmids. Am. J. Trop. Med. Hyg. 34:257.
19. King, D. L., and S. J. Turco. 1988. A ricin agglutinin-resistant clone of Leishmania donovani deficient in lipophosphoglycan. Mol. Biochem. Parasitol. 28:28.5.
20. Campbell, S. M., and P. M. Rainey. 1993. Leishmania pifanoi: kinetics of messenger RNA expression during amastigote to promastigote transformation in vitro. Exp. Parasitol. 77:1.
21. Ahmed, S., M. Colmenares, L. Soong, K. Goldsmith-Pestana, L. Munstermann, R. Molina, and D. McMahon-Pratt. 2003. Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infect. Immun. 71:401.
22. Sacks, D. L., S. Hieny, and A. Sher. 1985. Identification of cell surface carbohydrate and antigenic changes bctween noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135:564.
23. IIg, T., E. Handman, and Y. D. Stierhof. 1999. Proteophosphoglycans from Leishmania promastigotes and amastigotes. Biochem. Soc. Trans. 27:518.
24. Ilgoutz, S. C., and M. J. McConville. 2001. Function and assembly of the Leishmania surface coat. Int. J. Parasitol. 31:899.
25. Turco, S. J., and A. Descoteaux. 1992. The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46:65.
26. Soares, R. P., M. E. Macedo, C. Ropert, N. F. Gontijo, I. C. Almeida, R. T. Gazzinelli, P. F. Pimenta, and S. J. Turco. Leishmania chagasi: lipophosphoglycan characterization and binding to the midgut of the sand fly vector Lutzomyia longipalpis. Mol. Biochem. Parasitol. 121:213, 2002.
27. Karp, C. L., S. J. Turco. and D. L. Sacks. 1991. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum. J. Immunol. 147:680.
28. McConville, M. J., and S. W. Homans. 1992. Identification of the defect in lipophosphoglycan biosynthesis in a non-pathogenic strain of Leishmania major. J. Biol. Chem. 267:5855.
29. Puentes, S. M., R. P. Da Silva, D. L. Sacks, C. H. Hammer, and K. A. Joiner. 1990. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J. Immunol. 145:4311.
30. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell 111:927.
31. Afonso, L. C., and P. Scott. 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61:2952.
32. + T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158:5374.
33. Constant, S. L., J. L. Brogdon, D. A. Piggott, C. A. Herrick, I. Visintin, N. H. Ruddle, and K. Bottomly. 2002. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J. Clin. Invest. 110:1441.
34. Park, C. G., K. Takahara, E. Umemoto, Y. Yashima, K. Matsubara, Y. Matsuda, B. E. Clausen, K. Inaba, and R. M. Steinman. 2001. Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. Int. Immunol. 13:1283.
35. Wright, E. P., and E. R. el Amin. 1989. Leishmania infection: surfaces and immunity. Biochem. Cell Biol. 67:525.
36. Bahr, V., Y. D. Stierhof, T. IIg, M. Demar, M. Quinten, and P. Overath. 1993. Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana. Mol. Biochem. Parositol. 58:107.
37. Turco, S. J., G. F. Spath, and S. M. Beverley. 2001. Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol. 17:223.
38. Kamhawi, S., G. B. Modi, P. F. Pimenta, E. Rowton, and D. L. Sacks. 2000. The vectorial competence of Phlebotomus sergenti is specific for Leishmania tropica and is controlled by species-specific, lipophosphoglycan-mediated midgut attachment. Parasitology 121:25.
39. Sacks, D. L., G. Modi, E. Rowton, G. Spath, L. Epstein, S. J. Turco, and S. M. Beverley. 2000. The role of phosphoglycans in Leishmania-sand fly interactions. Proc. Natl. Acad. Sci. USA 97:406.